Drug recall · February 15, 2017
Aripiprazole Tablets recall
Why: Superpotent Drug: Product may not meet specifications throughout shelf life.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3.
- Lots / codes
Lot #: MJ7746, Exp 04/17
- Quantity
- 67,946 bottles
- Company
- Apotex Inc., Toronto, N/A
- Distribution
- Nationwide in the USA
- Initiated
- December 19, 2016 · Voluntary: Firm initiated
- Classified
- February 9, 2017
- Reported
- February 15, 2017
- Ended
- June 15, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.